Novo Nordisk Up, Legrand Plunges, Zalando Rises

On this episode of Stock Movers:
- Novo Nordisk shares rose after a judge denied Pfizer’s request to temporarily block the Danish drugmaker’s $10 billion bid to acquire the obesity startup Metsera.
- Legrand 3Q sales missed expectations as the boost from strong demand for data center infrastructure appeared to slow.
- Zalando shares rose after the online retailer reported 3Q sales that came ahead of expectations and confirmed its guidance for the full year.

See omnystudio.com/listener for privacy information.